A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis.
作者:
主题词
投药, 口服(Administration, Oral);青少年(Adolescent);成年人(Adult);老年人(Aged);变应原(Allergens);皮炎, 特应性(Dermatitis, Atopic);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);PPARγ(PPAR gamma);斑片试验(Patch Tests);病人满意度(Patient Satisfaction);回顾性研究(Retrospective Studies);危险因素(Risk Factors);抽样研究(Sampling Studies);疾病严重程度指数(Severity of Illness Index);噻唑烷二酮类(Thiazolidinediones);治疗结果(Treatment Outcome)
DOI
10.1001/archdermatol.2007.22
PMID
18209172
发布时间
2018-12-01
- 浏览6
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文